Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.

16 Sep 2015

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States.

16 Sep 2015

Tackling MRSA with bacteriophage

MRSA is bad news. If you've never heard of it, here's what you need to know: It's pronounced MER-suh, it's a nasty bacterial infection and it can cause serious disease and death.

15 Sep 2015

Bracket completes EXACT e-Diary Certification program on Android smartphone and tablet

Bracket, one of the industry's leading eCOA solutions providers today announced that it has completed the e-Diary Certification program with Evidera™ for the EXACT patient daily e-Diary on both an Android smartphone, and an Android Tablet.

15 Sep 2015

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials.

15 Sep 2015

Health experts call for action to improve health and well-being of women, children, adolescents

Societies are failing women, children and adolescents, particularly in the poorest communities around the world, and urgent action is needed to save lives and improve health, say global health experts.

15 Sep 2015

UTHealth's Paula Stigler-Granados awarded grant to conduct outreach, education on Chagas disease in South Texas

A researcher at The University of Texas Health Science Center at Houston School of Public Health was awarded a five-year, $544,329 grant from the Centers for Disease Control and Prevention to conduct outreach and education on Chagas disease in South Texas.

14 Sep 2015

Better treatment could be on the horizon for Myasthenia Gravis

Myasthenia Gravis (MG) is a debilitating and potentially deadly disease that can afflict anyone, characterized by severe muscle weakness, affecting control of facial expressions, arm and leg movements, chewing, swallowing, coughing and breathing. There is no cure, only treatment.

14 Sep 2015

Virginia Tech scientists discover new treatments to target antibiotic-resistant bacteria

Virginia Tech researchers have discovered a new group of antibiotics that may provide relief to some of the more than 2 million people in the United States affected by antibiotic resistance.

14 Sep 2015

Aridis' AR-301 granted FDA Fast Track Designation for treatment of pneumonia caused by S. aureus

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration granted Fast Track Designation to AR-301, the Company's fully human anti-Staphylococcal alpha-toxin IgG1 monoclonal antibody (mAb).

11 Sep 2015

CureVac, IAVI team up to advance development, testing of AIDS vaccines

The non-profit International AIDS Vaccine Initiative (IAVI) and biopharmaceutical company CureVac are partnering to accelerate the development of AIDS vaccines, utilizing novel immunogens developed by IAVI and partners, delivered via CureVac's novel messenger RNA (mRNA) technology.

10 Sep 2015

CureVac announces official launch of U.S. operations in Cambridge, MA

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.

10 Sep 2015

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

Healthy adults who get the flu vaccine may help protect not only themselves but also older adults in their community at higher risk for serious complications from influenza, suggest findings from a new study published in Clinical Infectious Diseases. Based on a national sample of more than 3 million people across eight flu seasons, researchers observed that seniors were up to 21 percent less likely to be diagnosed with flu-related illness if they lived in areas where more adults under 65 were immunized.

10 Sep 2015

Risk of illness and death increases when people migrate to urban slum areas

As an increasing proportion of the population in low- and middle-income countries migrates to urban slums areas, the risk of illness and death increases due to harmful environmental exposure.

10 Sep 2015

New nanozyme test can help curb Ebola spread in western Africa

A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.

10 Sep 2015

Nerve damage caused by leprosy linked to changes in the brain of patients

Brain plasticity is the ability of the brain to change both anatomically and functionally in response to changes in the body or in the environment.

10 Sep 2015

Report highlights remarkable decline in child mortality, but MDG target still missed by wide margin

Child mortality rates have plummeted to less than half of what they were in 1990, according to a new report released today. Under-five deaths have dropped from 12.7 million per year in 1990 to 5.9 million in 2015. This is the first year the figure has gone below the 6 million mark.

9 Sep 2015

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

Vernalis Therapeutics Inc., a subsidiary of Vernalis plc, today announced that Tuzistra XR (codeine polistirex and chlorpheniramine polistirex), extended-release oral suspension, CIII (DEA Schedule III) is now available to adult patients and physicians in the United States.

8 Sep 2015

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for immunotherapies, announced today that it has entered into a clinical supply and support agreement for the supply of MicronJet600, its microneedle delivery device, for use with Immune Design's oncology immunotherapy products from its ZVex discovery platform.

8 Sep 2015

Antibiotic resistance awareness: an interview with Professor Colin Garner

The threat of antibiotic resistance is very real. It is estimated that 700,000 people die each from resistant infections. In Europe the figure is 25,000 deaths and a similar number in the USA.

7 Sep 2015

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

NCOA and award-winning actress Judith Light support national educational initiative, Flu + You

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

Tackling MRSA with bacteriophage

Bracket completes EXACT e-Diary Certification program on Android smartphone and tablet

Study reveals how leukemia cells evade deadly effects of BRD4 inhibitors

Health experts call for action to improve health and well-being of women, children, adolescents

UTHealth's Paula Stigler-Granados awarded grant to conduct outreach, education on Chagas disease in South Texas

Better treatment could be on the horizon for Myasthenia Gravis

Virginia Tech scientists discover new treatments to target antibiotic-resistant bacteria

Aridis' AR-301 granted FDA Fast Track Designation for treatment of pneumonia caused by S. aureus

CureVac, IAVI team up to advance development, testing of AIDS vaccines

CureVac announces official launch of U.S. operations in Cambridge, MA

Healthy adults who receive flu vaccination may also help protect older adults at higher risk for flu-related complications

Risk of illness and death increases when people migrate to urban slum areas

New nanozyme test can help curb Ebola spread in western Africa

Nerve damage caused by leprosy linked to changes in the brain of patients

Report highlights remarkable decline in child mortality, but MDG target still missed by wide margin

Vernalis Therapeutics announces availability of codeine-based cough and cold syrup in the U.S.

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

Antibiotic resistance awareness: an interview with Professor Colin Garner

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in